The manuscript titled “Aberrant recursive splicing in a human disease locus” was accepted for publication in Cell Reports.
Authors include current Palmer Lab members Oksana Polesskaya, Rudy Avila, and Abraham Palmer.
Congratulations!
The manuscript titled “A phenome-wide association study of externalizing polygenic risk in the adolescent brain” was accepted for publication in Psychological Medicine.
Yixuan (Lawrence) Xu joined the Palmer Lab in August 2026 as a rotation student in the Bioinformatics and Systems Biology PhD program.
Welcome, Lawrence!
Dr. Palmer was invited to give a talk for the Psychiatric Institute & Center for Alcohol Research in Epigenetics Neuroscience Seminar Series at University of Illinois at Chicago on August 27, 2026.
Kalyani joined the Palmer Lab in August 2026 as a Data Processes Information Systems Analyst with the Bioinformatics team.
Welcome, Kalyani!
Dr. Montana Lara was selected to be a scholar in the Human Genetics Scholars Initiative program from the American Society of Human Genetics (ASHG).
Congratulations!
The manuscript titled “Data-driven RNA phenotyping captures genetically regulated dimensions of the transcriptome” was accepted for publication in the American Journal of Human Genetics.
Authors include current Palmer Lab members Daniel Munro and Abraham Palmer.
Congratulations!
Dr. Palmer gave a talk during the 49th Annual Scientific Meeting of the Research Society on Alcohol (RSA) on June 21, 2026 in San Antonio, Texas.
Dr. Palmer’s talk, “Using every part of the buffalo: how a large rodent genetics project encouraged spinoffs, collaborations and secondary data analyses,” was part of the round table session titled “From Biobanks to Behavior: How Shared Bioresources and Genetic Pipelines Drive Ethical Innovation in Preclinical Alcohol Research.”
Dr. Palmer gave a talk during the Annual Meeting of the College on Problems of Drug Dependence (CPDD) on June 17, 2026 in Portland, Oregon.
Dr. Palmer’s talk, “How it Begins: Initial Response to Opioids Strongly Predicts Self-Reported Opioid Use Disorder,” was part of the symposium session titled “Opioid Sensitivity as a Testable Behavioral Phenotype for Extramedical Opioid Use,” organized by Kelly Dunn.
Dr. Montana Lara was invited to give a talk at N@N—Neuroscience at Nemours—on June 17, 2026.
Dr. Lara’s talk, “Decoding complex neurobehavioral traits using multivariate genomic approaches” was hosted by Nemours Children’s Hospital and the University of Delaware.
